Evidencing leprosy neuronal inflammation by 18-Fluoro-deoxy-glucose.
Journal
PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488
Informations de publication
Date de publication:
Jun 2023
Jun 2023
Historique:
received:
12
12
2022
accepted:
16
05
2023
revised:
15
06
2023
medline:
19
6
2023
pubmed:
5
6
2023
entrez:
5
6
2023
Statut:
epublish
Résumé
Leprosy is caused by multiple interactions between Mycobacterium leprae (M. leprae) and the host's peripheral nerve cells. M. leprae primarily invades Schwann cells, causing nerve damage and consequent development of disabilities. Despite its long history, the pathophysiological mechanisms of nerve damage in the lepromatous pole of leprosy remain poorly understood. This study used the findings of 18F-FDG PET/CT on the peripheral nerves of eight lepromatous patients to evaluate the degree of glucose uptake by peripheral nerves and compared them with clinical, electrophysiological, and histopathological evaluations. Eight patients with lepromatous leprosy were included in this study. Six patients were evaluated up to three months after leprosy diagnosis using neurological examination, nerve conduction study, 18F-FDG PET/CT, and nerve biopsy. Two others were evaluated during an episode of acute neuritis, with clinical, neurophysiological, and PET-CT examinations to compare the images with the first six. Initially, six patients already had signs of peripheral nerve injury, regardless of symptoms; however, they did not present with signs of neuritis, and there was little or no uptake of 18F-FDG in the clinically and electrophysiologically affected nerves. Two patients with signs of acute neuritis had 18F-FDG uptake in the affected nerves. 18F-FDG uptake correlates with clinical neuritis in lepromatous leprosy patients but not in silent neuritis patients. 18F-FDG PET-CT could be a useful tool to confirm neuritis, especially in cases that are difficult to diagnose, such as for the differential diagnosis between a new episode of neuritis and chronic neuropathy.
Sections du résumé
BACKGROUND
BACKGROUND
Leprosy is caused by multiple interactions between Mycobacterium leprae (M. leprae) and the host's peripheral nerve cells. M. leprae primarily invades Schwann cells, causing nerve damage and consequent development of disabilities. Despite its long history, the pathophysiological mechanisms of nerve damage in the lepromatous pole of leprosy remain poorly understood. This study used the findings of 18F-FDG PET/CT on the peripheral nerves of eight lepromatous patients to evaluate the degree of glucose uptake by peripheral nerves and compared them with clinical, electrophysiological, and histopathological evaluations.
METHODS
METHODS
Eight patients with lepromatous leprosy were included in this study. Six patients were evaluated up to three months after leprosy diagnosis using neurological examination, nerve conduction study, 18F-FDG PET/CT, and nerve biopsy. Two others were evaluated during an episode of acute neuritis, with clinical, neurophysiological, and PET-CT examinations to compare the images with the first six.
RESULTS
RESULTS
Initially, six patients already had signs of peripheral nerve injury, regardless of symptoms; however, they did not present with signs of neuritis, and there was little or no uptake of 18F-FDG in the clinically and electrophysiologically affected nerves. Two patients with signs of acute neuritis had 18F-FDG uptake in the affected nerves.
CONCLUSIONS
CONCLUSIONS
18F-FDG uptake correlates with clinical neuritis in lepromatous leprosy patients but not in silent neuritis patients. 18F-FDG PET-CT could be a useful tool to confirm neuritis, especially in cases that are difficult to diagnose, such as for the differential diagnosis between a new episode of neuritis and chronic neuropathy.
Identifiants
pubmed: 37276237
doi: 10.1371/journal.pntd.0011383
pii: PNTD-D-22-01550
pmc: PMC10270593
doi:
Substances chimiques
Fluorodeoxyglucose F18
0Z5B2CJX4D
Glucose
IY9XDZ35W2
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0011383Informations de copyright
Copyright: © 2023 Penna et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
J Immunol. 2016 Sep 1;197(5):1905-13
pubmed: 27474073
Clin Nucl Med. 2018 Feb;43(2):132-133
pubmed: 29261639
Mem Inst Oswaldo Cruz. 2012 Mar;107(2):246-53
pubmed: 22415265
Clin Nucl Med. 2020 May;45(5):e236-e238
pubmed: 31977489
PLoS Negl Trop Dis. 2008 Apr 02;2(4):e212
pubmed: 18382604
J Clin Neurophysiol. 2010 Feb;27(1):38-47
pubmed: 20087206
Science. 2002 May 3;296(5569):927-31
pubmed: 11988579
Brain Behav. 2012 May;2(3):249-55
pubmed: 22741099
Cell. 2013 Jan 17;152(1-2):51-67
pubmed: 23332746
Future Microbiol. 2011 Feb;6(2):217-30
pubmed: 21366421
Lepr Rev. 2003 Dec;74(4):366-73
pubmed: 14750582
Lepr Rev. 1999 Mar;70(1):10-20
pubmed: 10405539
Clin Neurol Neurosurg. 2015 Apr;131:5-10
pubmed: 25655301
J Biol Chem. 2016 Oct 7;291(41):21375-21387
pubmed: 27555322
Lepr Rev. 1994 Dec;65(4):350-60
pubmed: 7861921
Indian J Dermatol Venereol Leprol. 2002 Mar-Apr;68(2):84-5
pubmed: 17656885
Immunol Rev. 2021 May;301(1):193-208
pubmed: 33913182